Optimized proteomic analysis of preserved biological tissue samples
Formalin-fixed paraffin-embedded tissue, or FFPE, is a valuable resource for proteomic studies needed to drive clinically relevant insights. However, obtaining patient-derived samples in sufficient numbers to represent different disease subtypes while also accounting for variables such as age and sex, poses a significant challenge.
To meet this challenge, Moe Haines, John Thorup, Michael Gillette, Shankha Satpathy and others in the Carr lab at the Broad Institute of MIT and Harvard presented an optimized workflow for enhanced proteomic analysis of FFPE samples. They published their findings in Molecular & Cellular Proteomics. In this workflow, they use a combination of pathology, guided dissection, Adaptive Focused Acoustics sonication, digestion and liquid chromatography-tandem mass spectrometry to identify up to 10,000 unique proteins and 11,000 fully localized phosphorylation sites in FFPE tissue. This work demonstrates the ability to derive biologically relevant results from clinically derived tumor samples and offers a significantly reduced overall processing time, thus widening the scope of analysis. This provides a useful avenue for more thorough proteomic analysis of preserved biological samples.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Differences in pili structure modulate bacterial behavior
Researchers demonstrate how small changes in the structure of hair-like protein appendages can affect the behavior of Acinetobacter bacteria.
Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.
Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.
Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.
The dual role of asprosin in chronic fatty liver disease
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.
Novel inhibitor targets RAS-driven cancers
Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.